Featured post
- Get link
- Other Apps
Healthline has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions, and medical associations. We avoid using tertiary references. You can learn more about how we ensure our content is accurate and current by reading our editorial policy.
- A study to evaluate a range of dose levels and vaccination intervals of Ad26.COV2.S in healthy adults and adolescents. (2021).
clinicaltrials.gov/ct2/show/NCT04535453 - Amit S, et al. (2021). Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients.
thelancet.com/journals/lancet/article/PIIS0140-6736(21)00448-7/fulltext - Baden LR, et al. (2020). Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine.
nejm.org/doi/full/10.1056/NEJMoa2035389 - CDC recommends use of Johnson & Johnson’s Janssen COVID-19 vaccine resume. (2021).
cdc.gov/coronavirus/2019-ncov/vaccines/safety/JJUpdate.html - Coronavirus disease (COVID-19). (2020).
who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-covid-19 - FDA and CDC lift recommended pause on Johnson & Johnson (Janssen) COVID-19 vaccine use following thorough safety review. (2021).
cdc.gov/media/releases/2021/fda-cdc-lift-vaccine-use.html - FDA issues emergency use authorization for third COVID-19 vaccine. (2021).
fda.gov/news-events/press-announcements/fda-issues-emergency-use-authorization-third-covid-19-vaccine - Frequently asked questions about COVID-19 vaccination. (2021).
cdc.gov/coronavirus/2019-ncov/vaccines/faq.html - Hall VJ, et al. (2021). COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): A prospective, multicentre, cohort study.
thelancet.com/journals/lancet/article/PIIS0140-6736(21)00790-X/fulltext - Janssen COVID-19 vaccine EUA fact sheet for recipients and caregivers. (2021).
fda.gov/media/146305/download - Janssen COVID-19 vaccine frequently asked questions. (2021).
fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/janssen-covid-19-vaccine-frequently-asked-questions - Johnson & Johnson’s Janssen COVID-19 vaccine overview and safety. (2021).
cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/janssen.html - Joint CDC and FDA statement on Johnson & Johnson COVID-19 vaccine. (2021).
fda.gov/news-events/press-announcements/joint-cdc-and-fda-statement-johnson-johnson-covid-19-vaccine - Lesson 3: Measures of risk. (2012).
cdc.gov/csels/dsepd/ss1978/lesson3/index.html - Moderna COVID-19 vaccine overview and safety. (2021).
cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Moderna.html - Pfizer-BioNTech COVID-19 vaccine overview and safety. (2021).
cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Pfizer-BioNTech.html - Polack FP, et al. (2020). Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine.
nejm.org/doi/full/10.1056/NEJMoa2034577 - Sadoff J, et al. (2021). Interim results of a phase 1-2a trial of Ad26.COV2.S COVID-19 vaccine.
nejm.org/doi/10.1056/NEJMoa2034201 - Sadoff J, et al. (2021). Safety and efficacy of single-dose Ad26.COV2.S vaccine against COVID-19.
nejm.org/doi/full/10.1056/NEJMoa2101544 - Tande AJ, et al. (2021). Impact of the COVID-19 vaccine on asymptomatic infection among patients undergoing pre-procedural COVID-19 molecular screening.
academic.oup.com/cid/advance-article/doi/10.1093/cid/ciab229/6167855 - Thompson MG, et al. (2021). Interim estimates of vaccine effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines in preventing SARS-CoV-2 infection among health care personnel, first responders, and other essential and frontline workers — eight U.S. locations, December 2020-March 2021.
cdc.gov/mmwr/volumes/70/wr/mm7013e3.htm
- Get link
- Other Apps